DIFC Innovation Hub, Dubai
i.DIFC Innovation Hub
ii.Dubai International Financial Centre
iii.Dubai, United Arab Emirates
An international pharmaceutical company focused on building, acquiring, commercializing and scaling pharmaceutical products across selected international markets.
Headquartered in Dubai, UAE — operating across selected international markets.
We are not intermediaries. TruMed acquires, develops and commercializes pharmaceutical products — taking commercial ownership of everything we bring to market.
We invest in regulatory approvals, commercial positioning and long-term market success, with a clear focus on execution, accountability and sustainable growth.
Disciplined ownership across the full commercial lifecycle of every product in our portfolio.
We selectively acquire and in-license pharmaceutical products, and invest in the development of products aligned with our commercial focus and long-term market strategy.
We take direct responsibility for bringing products to market — through our own sales and distribution capabilities, or carefully selected local commercial partners.
We actively manage product lifecycles, expand geographic reach, and invest in building sustainable brand equity and market share across our portfolio.
We create value for product owners and local market partners alike.
Commercial accountability over intermediation
Quality products supported by focused execution and scalable market impact
Long-term value creation alongside near-term opportunities
Strengthening partners to build stronger markets
Backed by a sponsor with approximately USD 1 billion market capitalization, enabling long-term investment and partnership stability.
Our leadership team brings over 100 years of combined global experience leading major international generic pharmaceutical companies.
Access to multiple markets across the globe through a wide commercial network.
We welcome inquiries related to commercial partnerships, product development collaboration, and market access opportunities.